Circadian rhythm disturbances in mood disorders: insights into the role of the suprachiasmatic nucleus

CA Vadnie, CA McClung - Neural plasticity, 2017 - Wiley Online Library
Circadian rhythm disturbances are a common symptom among individuals with mood
disorders. The suprachiasmatic nucleus (SCN), in the ventral part of the anterior …

Circadian rhythm disturbances in depression

A Germain, DJ Kupfer - Human Psychopharmacology: Clinical …, 2008 - Wiley Online Library
Objective The aim of this article is to review progress in understanding the mechanisms that
underlie circadian and sleep rhythms, and their role in the pathogenesis and treatment of …

Agomelatine, the first melatonergic antidepressant: discovery, characterization and development

C De Bodinat, B Guardiola-Lemaitre… - Nature reviews Drug …, 2010 - nature.com
Current management of major depression, a common and debilitating disorder with a high
social and personal cost, is far from satisfactory. All available antidepressants act through …

The novel melatonin agonist agomelatine (S20098) is an antagonist at 5-hydroxytryptamine2C receptors, blockade of which enhances the activity of frontocortical …

MJ Millan, A Gobert, F Lejeune, A Dekeyne… - The Journal of …, 2003 - Elsevier
Agomelatine (S20098) displayed p K i values of 6.4 and 6.2 at native (porcine) and cloned,
human (h) 5-hydroxytryptamine (5-HT) 2C receptors, respectively. It also interacted with h5 …

[BOK][B] Circadian physiology

R Refinetti - 2016 - books.google.com
Circadian rhythms influence most of our life activities, notably getting up and going to sleep
every day. The new edition of this book delves into the mechanisms surrounding how these …

Multi-target strategies for the improved treatment of depressive states: conceptual foundations and neuronal substrates, drug discovery and therapeutic application

MJ Millan - Pharmacology & therapeutics, 2006 - Elsevier
Major depression is a debilitating and recurrent disorder with a substantial lifetime risk and a
high social cost. Depressed patients generally display co-morbid symptoms, and depression …

New targets for rapid antidepressant action

R Machado-Vieira, ID Henter, CA Zarate Jr - Progress in neurobiology, 2017 - Elsevier
Current therapeutic options for major depressive disorder (MDD) and bipolar disorder (BD)
are associated with a lag of onset that can prolong distress and impairment for patients, and …

Serotonin 5-HT2C receptors as a target for the treatment of depressive and anxious states: focus on novel therapeutic strategies

MJ Millan - Therapies, 2005 - Elsevier
Abstract Serotonin (5-HT) 2C receptors play an important role in the modulation of
monoaminergic transmission, mood, motor behaviour, appetite and endocrine secretion …

Agomelatine: mechanism of action and pharmacological profile in relation to antidepressant properties

B Guardiola‐Lemaitre, C De Bodinat… - British Journal of …, 2014 - Wiley Online Library
Agomelatine behaves both as a potent agonist at melatonin MT1 and MT2 receptors and as
a neutral antagonist at 5‐HT2C receptors. Accumulating evidence in a broad range of …

Melatonin, sleep, and circadian rhythms: rationale for development of specific melatonin agonists

FW Turek, MU Gillette - Sleep medicine, 2004 - Elsevier
Circadian rhythm sleep disorders (CRSDs), whether chronic or transient, affect a broad
range of individuals, including many elderly, those with severe visual impairments, shift …